To download the current issue of HIT Perpectives Biopharma Insights via PDF, please click the thumbnail image to the right.
2020
HIT Perspectives (September 2020) – 
Achieving Patient-Specific Price Transparency by Unlocking EHR Data | Tapping Pharmacy Infrastructure and Clinical Services in a Changing World | Pulling Back the Covers on Health Information Exchanges: Part 1
HIT Perspectives (June 2020) –
Innovations in Formulary, Benefit and Eligibility To Transform the Point of Care Experience | Four Factors Driving the Momentum of Telehealth Adoption That Will Continue After the COVID-19 Crisis | Post COVID-19: Five Things That Will Come Roaring Back With a Twist
The Critical Role of Health IT in Fighting COVID-19 | Five Predictions on How the COVID-19 Crisis Will Transform Health IT | Take Note of the Health IT Opportunities Emerging From the Final Interoperability Rules of ONC and CMS
HIT Perspectives (February 2020) –
Top 2020 Health IT Predictions: Opportunities Abound | How Payers and Providers Can Succeed in Value-Based Care | FAST: The Coalition Aiming to Strengthen the FHIR Interoperability Infrastructure
2019
HIT Perspectives (December 2019) –
Four Reasons to Become a FHIRmacy | Five Key Ingredients for Successful Multistakeholder Initiatives | Digital Therapeutics: Transforming Care Through Technology
HIT Perspectives Biopharma Insights (September 2019) –
Three Essential Trends to Include in Q4 Planning | Lack of Training is Core Cause of Physician EHR Usability Complaints | ePA 2.0: Taking Electronic Prior Authorization to the Next Level
2018
HIT Perspectives Biopharma Insights (November 2018) –
New Federal Opioid Legislation Has Potential Impacts for All Pharmaceuticals | Connecting Patients With the Costs of their Medications
HIT Perspectives Biopharma Insights (September 2018) –
Automation of Specialty Pharmacy Gains Momentum | Six Interoperability Trends to Watch | Improving Drug Price Transparency: Progress and Opportunities
HIT Perspectives Biopharma Insights (June 2018) –
How Account Teams Can Help Ambulatory Physicians Succeed in the Era of Value-Based Care |Improving Drug Price Transparency: The Case for Out-of-Pocket Drug Cost Information at the Point of Prescribing | Thumbs Up at this ePrescribing Checkpoint!
HIT Perspectives Biopharma Insights (April 2018) –
Apple’s New App for Personal Health Information: Is It a Game Changer? | 10 Takeaways from HIMSS | The Da Vinci Project: Helping Payers and Providers Get the Most From Value-Based Care
HIT Perspectives Biopharma Insights (February 2018) –
Drug Benefit Cost Information at the Point of ePrescribing: What Lies Ahead | Top Trends to Watch in 2018 | Virtual Visits: Now Coming to Homes, Doctors and Pharmacies
2017
HIT Perspectives Biopharma Insights (November 2017) –
Following What the Doctor Ordered: Addressing Medication Noncompliance | The Impact of New, Nonproprietary Naming Convention for Biologics and Biosimilars: 7 Key Findings | ONC to Significantly Scale Back EHR Certification and Enrollment
HIT Perspectives Biopharma Insights (September 2017) –
The Electronic Health Record: A Valuable Tool for Brand Teams | Interoperability and Standards Will Be Areas of Focus Through Year End | Automating Enrollment for Specialty Prescriptions
HIT Perspectives Biopharma Insights (June 2017) –
Why Population Health Management Should Matter to Pharmaceutical Manufacturers | HHS Moves Ahead in Personnel and Health IT | New Maturity Model Will Help Spur Adoption of Electronic Prior Authorization
HIT Perspectives Biopharma Insights (April 2017) –
Eight Takeaways from HIMSS 2017 | FHIR Sets the Stage for Targeted Applications for Payers and Providers | Stakeholder Impacts of the AMA’s Prior Authorization Reform Proposal
HIT Perspectives Biopharma Insights (February 2017) –
10 Trends to Watch in 2017 | Will MACRA Be in the Crosshairs for Repeal and Replacement? | What the 21st Century Cures Act Means for Health IT
2016
HIT Perspectives Biopharma Insights (November 2016) –
Working Smarter, Not Harder: Helping Clinicians Optimize Use of EHRs | Computerized Order Sets Help Physicians Save Time and Improve Care | Electronic Dosing Instructions: Opportunities for Sales Teams
HIT Perspectives Biopharma Insights (September 2016) –
EHRs: A New Dissemination Tool for Patient Education Materials | Surescripts Issues its 2015 National Progress Report | Electronic Prior Authorization: Just What the Doctor Ordered (Almost)
HIT Perspectives Biopharma Insights (June 2016) –
New Proposed Regulation Rebrands and Retools Meaningful Use | Cutting Through the Confusion Surrounding Electronic Formulary and Benefit Checks | Retail Medical Clinics: Untapped Resources for Patient Education
HIT Perspectives Biopharma Insights (April 2016) –
Ten Takeaways from HIMSS16 | Integrating EHRs and PDMPs: How Vendors Can Get Ahead of the Curve | Alerting Prescribers for Biosimilar Substitution to Protect Patient Safety
HIT Perspectives Biopharma Insights (February 2016) –
Top Ten Health IT Trends for 2016 | Getting Doctors Ready for New York’s War on Opioid Abuse | Meaningful Use: Not Entirely Gone but Certainly Not Forgotten
2015
HIT Perspectives Biopharma Insights (November 2015) –
EHRS Can Expand the Quality and Scope of Physician Practices | Physicians’ Health, IT Priorities to Focus on ICD-10 and Meaningful Use | Why Care About the EHR Interoperability Brouhaha?
HIT Perspectives Biopharma Insights (September 2015) –
Five Ways Pharmaceutical Companies Can Leverage EHR Market Changes and Challenges | Better Formulary and Benefit Information Pay Off for Payers | FDA to Assess Role for EHRs in Clinical Trials
HIT Perspectives Biopharma Insights (June 2015) –
Surescripts Issues 2014 National Progress Report | Real-Time Benefit Check: Coming to the Point of Care | Efforts Under Way to Make REMS More Efficient and Less Burdensome
HIT Perspectives Biopharma Insights (May 2015) –
HIMSS15: On FHIR and 6 Other Key Takeaways | Meaningful Use Stage 3 Creates Opportunities for Pharma | The Impact of MU Stage 3 on Patient Engagement
HIT Perspectives Biopharma Insights (February 2015) –
Exciting Changes Ahead in 2015 for HealthIT | New York Leads Way in Electronic War Against Opiod Abuse | EHRs: A Tool to Improve Vaccine Use
2014
HIT Perspectives Biopharma Insights (December 2014) –
Biosimilars: Opportunity Knocks – Building a Better Technology Mousetrap | Improved Prescription Information: The Key to Closing the Medication Adherence Gap | Drug Databases: A Growing Resource for Patient Care and Safety
HIT Perspectives Biopharma Insights (September 2014) –
What’s Next for EHR Market Consolidation? | Growing Use of Oral Specialty Medications to Spur ePrescribing Adoption | Real-World Evidence Comes to Mainstream Health Care
HIT Perspectives Biopharma Insights (July 2014) –
Meaningful Use Learnings for Pharmaceutical Companies | Deciphering the Mystery of Population Health Management |Surescripts Stats Show ePrescribing Rounds Third Base
HIT Perspectives Biopharma Insights (April 2014) –
Guidelines and Best Practices: Ripe for an Assist from Managed Markets Teams | What’s Next for Meaningful Use? | Improving Adoption of Clinical Decision Support
HIT Perspectives Biopharma Insights (March 2014) –
Improving ePrescribing as an Important Tool for Managed Markets | The Top Ten Health IT Trends for 2014 | Accelerating ePrescribing for Controlled Substances
